Search results
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 3 hours agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 49 minutes agoIts vast scale, expertise, and growing innovation capabilities set it up for robust performance in the coming decade and beyond. Why is Pfizer's stock...
Retiree calls out Sask. gov't for not communicating changes to accessing COVID-19 drug Paxlovid
CBC via Yahoo News· 14 hours agoWhen Greg Pletz contracted COVID-19 in mid-May, he called the Saskatchewan 811 HealthLine and was...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 1 day agoIf you've been on the sidelines, now could be a great time to buy the stock. Shares of Pfizer have...
Pfizer's Options Frenzy: What You Need to Know - Pfizer (NYSE:PFE)
Benzinga· 6 days agoInsights into Volume & Open Interest Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Pfizer ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 5 days agoQ1 Earnings & Sales Top, EPS Guidance Raised Pfizer’s first-quarter results were strong as it beat...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 6 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
